Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,933,000 | 3,160,000 | 3,585,000 | 2,855,000 | 1,988,000 |
| Receivables | 13,122,000 | 11,523,000 | 12,868,000 | 12,656,000 | 13,081,000 |
| Inventories | 3,256,000 | 3,545,000 | 3,293,000 | 3,521,000 | 3,539,000 |
| Other current assets | 941,000 | 1,150,000 | 544,000 | 538,000 | 614,000 |
| TOTAL | $20,252,000 | $19,378,000 | $20,290,000 | $19,570,000 | $19,222,000 |
| Non-Current Assets | |||||
| PPE Net | 7,213,000 | 7,213,000 | 6,803,000 | 6,663,000 | 6,605,000 |
| Intangibles | 13,729,000 | 13,818,000 | 13,602,000 | 13,656,000 | 13,707,000 |
| Other Non-Current Assets | 10,243,000 | 10,301,000 | 10,078,000 | 9,714,000 | 9,714,000 |
| TOTAL | $31,185,000 | $31,332,000 | $30,483,000 | $30,033,000 | $30,026,000 |
| Total Assets | $51,437,000 | $50,710,000 | $50,773,000 | $49,603,000 | $49,248,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 506,000 | 500,000 | 1,000,000 | 500,000 | 1,250,000 |
| Accounts payable and accrued liabilities | 1,889,000 | 880,000 | 1,491,000 | 1,453,000 | 3,166,000 |
| Accrued Expenses | 2,794,000 | 3,163,000 | 2,818,000 | 2,488,000 | 2,022,000 |
| Other current liabilities | 2,273,000 | 1,845,000 | 2,538,000 | 2,966,000 | 2,009,000 |
| TOTAL | $14,717,000 | $13,933,000 | $15,201,000 | $14,888,000 | $15,652,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,657,000 | 11,669,000 | 11,675,000 | 12,174,000 | 11,439,000 |
| Deferred Revenues | 7,255,000 | 7,545,000 | 7,354,000 | 7,481,000 | 7,205,000 |
| Other Non-Current Liabilities | 18,709,000 | 19,047,000 | 18,878,000 | 18,720,000 | 18,629,000 |
| TOTAL | $30,387,000 | $30,739,000 | $30,586,000 | $30,929,000 | $30,109,000 |
| Total Liabilities | $45,104,000 | $44,672,000 | $45,787,000 | $45,817,000 | $45,761,000 |
| Shareholders' Equity | |||||
| Common Shares | 278,000 | 279,000 | 278,000 | 278,000 | 279,000 |
| Retained earnings | 21,977,000 | 21,636,000 | 19,844,000 | 18,876,000 | 18,708,000 |
| Other shareholders' equity | -16,008,000 | -16,121,000 | -15,259,000 | -15,403,000 | -15,541,000 |
| TOTAL | $6,312,000 | $6,015,000 | $4,953,000 | $3,751,000 | $3,446,000 |
| Total Liabilities And Equity | $51,416,000 | $50,687,000 | $50,740,000 | $49,568,000 | $49,207,000 |